Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapy

Low pretreatment testosterone level may be a marker for men at increased risk of premature death with ADT. The combination of low pretreatment serum testosterone level and multiple preexisting comorbidities is associated with decreased OS when ADT is incorporated into treatment.